A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis

Introduction: Multiple sclerosis is the most prevalent chronic autoimmune disease of the central nervous system with the first clinical symptoms typically appearing in early adulthood, and affecting over 2 million people worldwide (1). Relapsing-remitting multiple sclerosis (RRMS) is the current...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Herrera, María Inés, Kölliker Frers, Rodolfo, Otero Losada, Matilde, Pérez Lloret, Santiago, Filippo, Macarena, Tau, Julia, Capani, Francisco, Villa, Andrés M.
Formato: Artículo
Lenguaje:Inglés
Publicado: Frontiers In 2019
Materias:
ESCLEROSIS MULTIPLE
DISCAPACIDAD
CITOQUINAS
ENFERMOS
ENFERMEDADES AUTOINMUNES
Acceso en línea:https://repositorio.uca.edu.ar/handle/123456789/9158
Aporte de:
Repositorio Institucional de la Universidad Católica Argentina (UCA) de Universidad Católica Argentina
id I33-R139123456789-9158
record_format dspace
institution Universidad Católica Argentina
institution_str I-33
repository_str R-139
collection Repositorio Institucional de la Universidad Católica Argentina (UCA)
language Inglés
topic ESCLEROSIS MULTIPLE
DISCAPACIDAD
CITOQUINAS
ENFERMOS
ENFERMEDADES AUTOINMUNES
spellingShingle ESCLEROSIS MULTIPLE
DISCAPACIDAD
CITOQUINAS
ENFERMOS
ENFERMEDADES AUTOINMUNES
Herrera, María Inés
Kölliker Frers, Rodolfo
Otero Losada, Matilde
Pérez Lloret, Santiago
Filippo, Macarena
Tau, Julia
Capani, Francisco
Villa, Andrés M.
A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis
topic_facet ESCLEROSIS MULTIPLE
DISCAPACIDAD
CITOQUINAS
ENFERMOS
ENFERMEDADES AUTOINMUNES
description Introduction: Multiple sclerosis is the most prevalent chronic autoimmune disease of the central nervous system with the first clinical symptoms typically appearing in early adulthood, and affecting over 2 million people worldwide (1). Relapsing-remitting multiple sclerosis (RRMS) is the current criteria-based most prevalent form of the three clinical presentations of multiple sclerosis (MS), relapsing-remitting, converted to secondary progressive, and primary progressive. It is characterized by neurologic worsening attacks or relapses followed by apparent recovery periods of masked progression of the disease...
format Artículo
author Herrera, María Inés
Kölliker Frers, Rodolfo
Otero Losada, Matilde
Pérez Lloret, Santiago
Filippo, Macarena
Tau, Julia
Capani, Francisco
Villa, Andrés M.
author_facet Herrera, María Inés
Kölliker Frers, Rodolfo
Otero Losada, Matilde
Pérez Lloret, Santiago
Filippo, Macarena
Tau, Julia
Capani, Francisco
Villa, Andrés M.
author_sort Herrera, María Inés
title A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis
title_short A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis
title_full A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis
title_fullStr A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis
title_full_unstemmed A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis
title_sort pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-h and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis
publisher Frontiers In
publishDate 2019
url https://repositorio.uca.edu.ar/handle/123456789/9158
work_keys_str_mv AT herreramariaines apilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT kollikerfrersrodolfo apilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT oterolosadamatilde apilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT perezlloretsantiago apilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT filippomacarena apilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT taujulia apilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT capanifrancisco apilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT villaandresm apilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT herreramariaines pilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT kollikerfrersrodolfo pilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT oterolosadamatilde pilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT perezlloretsantiago pilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT filippomacarena pilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT taujulia pilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT capanifrancisco pilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
AT villaandresm pilotcrosssectionalstudytoinvestigatethebiomarkerpotentialofphosphorylatedneurofilamenthandimmunemediatorsofdisabilityinpatientswith5yearrelapsingremittingmultiplesclerosis
bdutipo_str Repositorios
_version_ 1764820529142824963

Ejemplares similares